about
Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition.Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.Prospective memory performance in non-psychotic first-degree relatives of patients with schizophrenia: a controlled study.Regional homogeneity within the default mode network in bipolar depression: a resting-state functional magnetic resonance imaging study.Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trialsLongitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophreniaPrevalence and prescription of antidepressants in depression with somatic comorbidity in Asia: the Research on East Asian Psychotropic Prescription Patterns study.Association between Tourette syndrome and the dopamine D3 receptor gene rs6280.Clozapine in China.Clozapine for treatment-resistant bipolar disorder: a systematic review.QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis.QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates.Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.Alteration of spontaneous neuronal activity within the salience network in partially remitted depression.Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials.Prospective memory deficits in euthymic bipolar disorder patients: a preliminary study.The ANK3 gene and facial affect processing: An ERP study.Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients.Socio-demographic and clinical profiles of paranoid and nonparanoid schizophrenia: a prospective, multicenter study in China.Effect of rs1344706 in the ZNF804A gene on the connectivity between the hippocampal formation and posterior cingulate cortex.The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study.Psychopharmacological treatment for schizophrenia: less is more.Childhood trauma associates with clinical features of schizophrenia in a sample of Chinese inpatients.Proper use of clozapine: experiences in China.Sex differences in patients with schizophrenia: A prospective, multi-center study.Cigarette smoking in patients with schizophrenia in China: prospective, multicentre study.Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009.Experiential pleasure deficits in different stages of schizophrenia.Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.Prescribing patterns of low doses of antipsychotic medications in older Asian patients with schizophrenia, 2001-2009.The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers.Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).Adjunctive antidepressant prescriptions for hospitalized patients with schizophrenia in Asia (2001-2009).Difference in amplitude of low-frequency fluctuation between currently depressed and remitted females with major depressive disorder.Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies.The contribution of the contingent negative variation (CNV) to goal maintenance.
P50
Q28943275-9ED2769B-F74A-42E3-BDDF-AAAB78798C63Q30358899-B914C0EC-226C-4E9A-A2C1-7E4FC4C607E5Q33571417-111F13A5-960C-4CC1-87CD-E96D3C2F246DQ34445488-A37033ED-68D0-4886-9987-FBFF25A0C952Q34469621-29CFC5CC-FA65-4DD4-8F96-96E5CB627D86Q34925151-12DEE010-446A-4BAE-8350-EC887F6AF729Q36292901-B747F70E-9929-47A7-8F7E-B379236129DEQ36804835-94239B0F-9354-42E9-B662-BF63FC3E8926Q36807163-931D2443-338B-4A97-86CD-ECF8E3AE0EEEQ37059795-1B9C8C35-0968-49DB-855A-717932C39007Q38262870-7F675B28-C4AB-4FFF-9F45-CAEA7C718D44Q38296631-BD764E74-CC32-4374-B3D3-1BED4C2BECC0Q38328258-C3175DD1-139B-44D0-999F-D4FF99F0F876Q38364637-86DE5C51-3C6F-447C-B01C-63DE9BA48FCBQ38674402-A2F35C7A-6F7A-460E-A1EA-17A95D661382Q39065348-1CC4FD09-1875-4669-A804-34B1D00F179AQ39127101-50DA3BBD-601D-4692-8546-601FBA5A6C3AQ39276653-CC700B90-1C0B-4F74-8DD4-1BA4A4BF9214Q39384048-16350F8C-3478-4F67-A4E7-E118791F0555Q39768241-476079C1-4B24-4074-BBBE-8A8008E098A9Q39821093-10AA0866-EB01-4BB2-8BAB-EAF8ECE1DBA3Q39894337-3DF9CE7F-D945-4130-837B-CBA1184C1F95Q39988669-60BFF610-F8C8-49A8-80E2-CC8880888DB4Q40224966-B0DAA992-F469-42A3-8644-67D53C96D552Q40830469-6F090B54-A47E-4346-98C4-9A78949FFC83Q41078277-EA2BC405-67B2-4186-A90B-B5F13EA1BFA6Q41652386-41DEB8FA-F4C6-428A-8C88-88413AF2DA5FQ41819342-7149B7BA-53C8-4948-BCAE-2E37CA579FC5Q43086459-8A7C7287-2C63-4007-9348-917BA863C5E0Q43096642-BAA1BE33-9F2C-40CF-87DA-840D9FBD2253Q43511566-C611EAB4-7FB8-4E09-8D73-7E0DEB09FE84Q43773608-885FC722-941E-4702-BCFC-FC54ADD4D078Q44179596-4D7A289E-9A11-4147-968B-A337F4D393D1Q44490282-C8E46B38-6569-4A4A-80B6-BC5D50AE31A5Q44938175-12B3AE47-0BB9-4F1F-8CB7-0AAEF4E04E68Q45208844-01ADB279-177C-4026-A558-27096AF5218AQ45227771-DB812FEE-4241-4177-8C6A-590965ADEB95Q45417029-4254D0DB-D4FF-4A05-A30B-2D8C0C6171FFQ45732990-087211DC-84C2-47D3-9847-40368E2573BFQ45961549-D6BA19DD-55C0-4FED-BB2B-BFAAAA7EC7F5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chuan-Yue Wang
@ast
Chuan-Yue Wang
@en
Chuan-Yue Wang
@es
Chuan-Yue Wang
@sl
type
label
Chuan-Yue Wang
@ast
Chuan-Yue Wang
@en
Chuan-Yue Wang
@es
Chuan-Yue Wang
@sl
prefLabel
Chuan-Yue Wang
@ast
Chuan-Yue Wang
@en
Chuan-Yue Wang
@es
Chuan-Yue Wang
@sl
P1053
C-9369-2015
P106
P31
P3829
P496
0000-0001-6549-3713
P569
2000-01-01T00:00:00Z